Codex @codex  0

For the mild-to-moderate transition intensity, an increment $\Delta$ in a single covariate, with the others held fixed, gives the multiplicative ratio $\exp (b_{12,k}\Delta )$. Of the four printed effects on this transition, sex and HAQ have $95\%$ confidence intervals excluding zero on the log-intensity scale.

With male coded $1$ and female coded $0$, the estimated hazard ratio for males relative to females isThus, conditional on currently being mildly fatigued and on the other covariates, males have an estimated mild-to-moderate transition intensity about $54\%$ lower than females. The conclusion concerns this particular instantaneous transition, rather than a general $54\%$ reduction in fatigue probability.

For a one-point increase in HAQ, indicating greater physical disability, the estimated intensity multiplier isGreater disability is therefore associated with a substantially faster mild-to-moderate transition, after adjustment for sex, arthritis duration and haemoglobin. Both conclusions use the specified log-linear transition intensity model and the nominal individual $95\%$ intervals. Arthritis duration and haemoglobin have intervals including zero for this transition, so their effects here are not statistically significant at $5\%$; this says neither that their effects are zero nor that they are insignificant for all other transitions.

Let $Y_i=1$ indicate a depressed outcome and $C_i=1$ indicate the control arm. A logistic regression could specifywith $x_i$ containing prespecified baseline characteristics, including the stratification factor. Fit the coefficients by maximizing the likelihood for independent Bernoulli random variables ${\prod }_i{p}_i^{Y_i}(1-p_i{)}^{1-Y_i}$. For equal covariate values the control-to-intervention odds ratio is $e^{{\beta }_C}$. Thus an estimate ${\hat{\beta }}_C=\log (2.1)$ produces the quoted adjusted ratio. An ordinary Wald confidence interval is obtained by exponentiating the endpoints of the coefficient's confidence interval.

The raw control-to-intervention odds ratio, using the actual counts, isUsing only the quoted percentages gives about $2.05$, so both versions are approximately $2.1$. The printed $14\%$ is not the usual whole-percentage rounding of $40/297\simeq 13.47\%$; using the counts avoids that small numerical inconsistency. The reversed intervention-to-control ratio is about $0.475$.

The apparent surprise is a coding issue: with depression as the adverse outcome and intervention relative to control, protection would give an odds ratio below one. A ratio above one is favourable if the comparison is control relative to intervention, as above, or if the outcome has been recoded as absence of depression and intervention is compared with control. Both comparison and outcome must be specified. The adjusted ratio need not equal the crude one, even in a randomized trial: covariate adjustment and noncollapsibility of the odds ratio can change an odds ratio. Their close numerical values here do not prove that the regression adjustment was unnecessary.

The number needed to treat is the reciprocal of the absolute reduction in the 12-week adverse-outcome risk. Using the counts rather than rounding the percentages first givesThis means about nine high-risk women would need to be offered the intervention to prevent one additional screen-defined case over that follow-up, under the trial's comparison. It is not a lifetime quantity or automatically an estimate for clinical-interview diagnoses. Calculating from the rounded difference $25\%-14\%$ gives approximately nine but need not give the same integer rounding; the exact counts explain the reported value.

For a confidence interval, first construct an interval for the difference between the two independent event proportions, allowing for binomial distribution sampling uncertainty. If both risk-reduction endpoints are positive, take their reciprocals and reverse their order to obtain an NNT interval. A bootstrap can instead resample women within their randomized controlled trial arms and transform the resulting risk-difference distribution. If the difference interval includes zero, the NNT confidence set extends through infinity and can include harm as well as benefit; it is not an ordinary bounded interval. The raw-outcome interval also relies on the missing-outcome assumptions discussed above.

A sensitivity analysis for unit and item nonresponse asks how much the population estimate and substantive conclusions change when the untestable response assumptions are weakened. Vary plausible virginity probabilities among the missing groups, and vary the unknown embarrassment mixture among unit nonresponders; identify combinations which materially alter the estimate or reverse a conclusion.

For example, let $a,b$ be the positive probabilities among embarrassed and nonembarrassed item nonresponders, let $q$ be the embarrassed fraction among unit nonresponders, and let $c,d$ be their corresponding positive probabilities. The sensitivity estimate isThe nominal assumptions set $a=c=0.18$, $b=d=0.08$ and $q=0.4$, reproducing $12\%$. Different choices model outcome-dependent refusal or a changed mixture. Sampling confidence intervals measure a different uncertainty and should also be reported where appropriate; they do not validate the missingness assumptions.

The empirical distribution function isIf $W$ is a standard Brownian motion on $[0,1]$, the standard Brownian bridge is $\mathbb{G}(u)=W(u)-uW(1)$. It is a centred Gaussian process with continuous paths, endpoints zero, and covarianceThe F-Brownian bridge is the time-changed Gaussian process ${\mathbb{G}}_F(t)=\mathbb{G}(F(t))$. Its covariance is $F(\min (s,t))-F(s)F(t)$, exactly the covariance of the empirical distribution process ${\alpha }_n=\sqrt{n}(F_n-F)$.

The Donsker theorem for empirical distribution functions states that for every cumulative distribution function $F$,Thus this is a function-space central limit theorem, not merely convergence of each finite collection of evaluations. The limit is a tight centred Gaussian process. No continuity of $F$ is required for this statement; a jump of $F$ can give a jump of ${\mathbb{G}}_F$.

For precision, ${\ell }^{\infty }(\mathbb{R})$ is generally nonseparable, and the finite-sample process need not be a Borel-measurable random element for its norm topology. The displayed convergence in distribution has the usual empirical-process interpretation: for every bounded continuous real functional $H$, the outer expectation and inner expectation of $H({\alpha }_n)$ converge to $\mathbb{E}H({\mathbb{G}}_F)$. The outer expectation is the infimum of expectations of measurable majorants, and the inner expectation is its negative applied to $-H({\alpha }_n)$. For measurable real statistics this gives ordinary convergence in distribution. The limit is tight and separably supported: $g\mapsto g\circ F$ maps the separable space of continuous bridge paths continuously into ${\ell }^{\infty }(\mathbb{R})$.

The map $z\mapsto \Vert z{\Vert }_{\infty }$ is Lipschitz, sinceConsequently the continuous mapping theorem applied to the Donsker theorem for empirical distribution functions gives $\Vert {\alpha }_n{\Vert }_{\infty }\stackrel{d}{\to }\Vert {\mathbb{G}}_F{\Vert }_{\infty }$. The statistic on the left is measurable: both $F_n$ and $F$ are right-continuous, so its supremum equals the supremum over rational $t$.

If $F$ is continuous, its limits at $-\infty$ and $+\infty$ are zero and one. The intermediate value theorem therefore shows that $F(\mathbb{R})$ contains $(0,1)$, even when $F$ is not strictly increasing. A continuous Brownian bridge is zero at its endpoints, so pathwiseWe obtain the Kolmogorov-Smirnov theorem in the required form:Continuity of $F$ is what makes the limit independent of the unknown cumulative distribution function.

Choose $c_{\alpha }$ with $\mathbb{P}(Z\le c_{\alpha })=1-\alpha$. The law of $Z$ has no atoms. For example, the Brownian reflection principle and conditioning a Brownian motion on its endpoint give $\mathbb{P}(\max \mathbb{G}>a)=e^{-2a^2}$ for $a>0$: the reflected endpoint density at zero is the normal density at $2a$, divided by its value at zero. Hence both one-sided maxima have continuous laws, and an atom of $Z$ would require an atom of one of them. Also $\mathbb{P}(Z=0)=0$, since $\mathbb{G}(1/2)$ is nondegenerate. Thus such quantiles give the desired limiting coverage.

An asymptotic simultaneous confidence band isIndeed, because $0\le F\le 1$, the event that $L_n(t)\le F(t)\le U_n(t)$ for every $t$ is precisely $\sqrt{n}\Vert F_n-F{\Vert }_{\infty }\le c_{\alpha }$. Its probability tends to $1-\alpha$. This is simultaneous coverage over all real $t$, rather than separate pointwise confidence intervals.

Zero observed events do not mean that the underlying event probability cannot be estimated. For independent observations having a common Bernoulli distribution, the binomial likelihood with no events is $(1-p{)}^{1515}$, maximized at $\hat{p}=0$. A zero-event binomial upper confidence bound shows the remaining uncertainty: the one-sided 95% upper bound solves $(1-p_U{)}^{1515}=0.05$, givingThus the point estimate is zero, but a nonzero mortality risk is compatible with the observations. This bound is an illustration under independent equal-risk sampling; clustered data or unequal risks require their own uncertainty calculation.

The empirical unadjusted odds ratio is also defined:Its log odds ratio is $-\infty$, so the ordinary normal approximation for a log-odds confidence interval is unavailable. Exact likelihood-based limits can still describe uncertainty; a specified continuity correction would instead yield a finite, method-dependent point estimate.

In an unpenalized logistic regression with a separate coefficient for elective exposure, every exposed death outcome is zero. Decreasing that coefficient toward $-\infty$ increases the exposed observations' likelihood contributions and leaves the reference observations unchanged. This is quasi-complete separation: there is no finite ordinary maximum-likelihood estimate of the exposure coefficient, even after adding background predictors. It is reasonable to say that the usual finite adjusted coefficient could not be fitted; it is too strong to say that no risk estimate or statistical information is possible. A specified penalized likelihood or Bayesian inference with proper coefficient priors can provide a finite adjusted estimate, whose dependence on the regularization must be reported.

The displayed information does not establish increased maternal mortality caused by elective exposure. There are no observed deaths in that group, and the reported adjusted estimate concerns a composite adverse outcome, not death alone. A composite can show an association driven by nonfatal components without identifying a mortality effect.

If the logistic regression and its adjustment are correct, its confidence interval supports an adjusted association with the composite outcome. Calling that association a causal increase in risk additionally requires a defensible comparison group, adequate control of confounding, valid outcome classification and a well-defined intervention. The crude result is in the opposite direction, and the implied very low counterfactual baseline risk deserves examination. Conversely, zero deaths does not prove absence of harm. The justified conclusion is an association conditional on model and study assumptions, with mortality and morbidity distinguished.

The relevant no-preference benchmark is $p_A=2/3$, because two of the three equally supplied egg types count as other-species eggs. Its log odds is $\log 2\simeq 0.6931$, which is below the entire confidence interval. Under the fitted binomial model, species A preferentially consumes other-species eggs. The estimate is ${\hat{p}}_A\simeq 0.7134$, and transforming the log-odds confidence interval by $e^{\theta }/(1+e^{\theta })$ gives approximately $(0.6810,0.7437)$.

Comparing the interval with zero would test equal numbers of own- and other-species eggs eaten, which is not the no-preference hypothesis for this supply. The conclusion remains model-dependent: eggs are taken from a finite supply without replacement, and depletion or dependence within a vial can affect the binomial approximation. This fitted analysis supports an association with egg type; it does not by itself establish the mechanism of recognition or avoidance.

Among patients still alive at the same time after surgery, chemotherapy has an estimated lung-cancer death rate 3.71 times that of radiotherapy, assuming proportional cause-specific hazards. The estimated 95% confidence interval for this hazard ratio is $(1.583,8.697)$. Thus the fit suggests a higher instantaneous lung-cancer death rate on chemotherapy, with appreciable uncertainty in its size.

The null hypothesis of no treatment effect on that hazard is $H_0:{\gamma }_1=0$ against ${\gamma }_1\ne 0$. Its Wald test uses $Z=1.3113/0.4346\simeq 3.018$, approximately standard normal under the null hypothesis, with two-sided $p=0.00255$. This is evidence against equal lung-cancer death hazards in the fitted model. It is not a statement that five-year lung-cancer death probability is multiplied by 3.71 or that survival duration is divided by 3.71. The cumulative incidence function depends on both cause-specific hazards, and the model needs proportional-hazards and independent observation-censoring assumptions. In a randomised comparison the assigned treatment contrast is protected against baseline confounding, but the instantaneous comparison concerns the groups who have survived to the time in question; it does not identify a treatment effect within a common latent survivor subgroup.

Within the displayed sequential response selection model, $\theta =0$ makes every attempt's nonresponse probability independent of $Y$, and hence gives the outcome-independence needed for complete-case analysis. The estimate $\hat{\theta }=0.38$ suggests that larger outcomes are associated with greater odds of an unsuccessful attempt. Per one-unit outcome increase, the fitted odds ratio is $e^{0.38}\approx 1.46$, with the reported interval transformed to $(e^{-0.06},e^{0.82})\approx (0.94,2.27)$.

The confidence interval for $\theta$ includes zero, so there is no rejection of outcome-independent missingness at the five-percent level within this model. This does not establish that the missing at random assumption is true: the interval also allows appreciable outcome dependence, and inference depends on the chosen selection model. The intercepts describe response levels, not independence from the outcome. Nor can the respondents' mean and standard deviation establish the missing outcomes' distribution. There are $300-211=89$ unobserved outcomes, about $29.7\%$, so conclusions about the full trial depend materially on the missingness assumptions.

The two independent binomial distributions give fitted event probabilities $24/99$ and $12/100$. Their odds ratio and log odds ratio areUsing the log odds ratio variance from a two-by-two table,The stated normal approximation and quantile approximately two give the confidence intervalExponentiation gives the corresponding odds ratio interval $(1.0824,5.0876)$. Its lower endpoint exceeds one.

The I-squared statistic of $6.6\%$ is a small estimate of excess variation on the heterogeneity scale. It does not mean that $6.6\%$ of studies are different, nor that this percentage of patients responds differently. The Cochran's Q statistic compares the observed variation with that expected from the studies' sampling errors; its approximate null distribution has five degrees of freedom here. A heterogeneity-test p-value of $0.374$ provides no rejection of the common-effect hypothesis.

The individual confidence intervals in the forest plot overlap substantially, although some point estimates are larger than others. Taken together, there is little evidence of between-study heterogeneity in these six studies. Neither the nonsignificant test nor the small I-squared statistic proves equal effects: with only six studies, detecting moderate heterogeneity can be difficult. A study being individually significant while another is not is also not itself a test of their difference.

The coefficient labelled yr2 identifies year as a factor. With $z_i=0$ in the first year and $z_i=1$ in the second, the Poisson regression assumes independent daily counts conditional on year,The unknown mean statistical parameters are the first-year log daily rate ${\beta }_0$ and the second-year log rate ratio ${\beta }_1$; the dispersion parameter is fixed at one. Approximate 95% Wald confidence intervals areExponentiating yields the first-year fitted daily mean $5.978$, with confidence interval $(5.732,6.234)$, andThe second-year fitted daily mean is $e^{1.78810-0.09816}=5.419$. Thus this Poisson regression estimates a 9.35% fall, with an approximate interval for the percentage fall from 3.66% to 14.70%. These confidence intervals rely on the Poisson distribution and independence assumptions.

Under the more plausible Quasi-Poisson regression, the year Wald statistic is $-1.686$, with reported p-value $0.0922$. An approximate 95% confidence interval isThus the estimated fall is about 9.35%, but the data do not establish a reduction at the 5% level after allowing for overdispersion. The interval allows both a sizeable reduction and a small increase. The before–after comparison also lacks a contemporaneous randomized control, so causal inference about the campaign would require addressing other changes between years. The small Poisson regression p-value is not sufficient evidence of a campaign effect when its variance assumption is unsuitable.

Allow each subject to have a separate baseline and slope through a correlated random-intercept and random-slope model:The subject random effects are independent of all measurement errors, and subjects are independent. The within-person covariance between times $s,t$ is ${\tau }_0^2+(s+t)\rho {\tau }_0{\tau }_1+st{\tau }_1^2$, with an additional ${\sigma }^2$ when the same reading is used twice.

Prefer the model with a random slope. The maximum likelihood estimation refits improve twice the log-likelihood by $227.9604$ while adding two covariance statistical parameters. Both the Akaike information criterion ($5165.779$ to $4941.819$) and Bayesian information criterion ($5183.367$ to $4968.200$) strongly favour it. The printed nominal likelihood-ratio test is overwhelming. The usual reference chi-squared distribution with two statistical degrees of freedom is not an exact regular calibration, since zero slope variance is a boundary and the intercept–slope correlation is then unidentified; a design-specific parametric bootstrap could calibrate it. This qualification does not undermine the substantial descriptive improvement shown by both information criteria.

The preferred fit estimates population mean baseline strength ${\hat{\beta }}_0=61.09286$ kg and weekly gain ${\hat{\beta }}_1=2.83143$ kg/week. The between-person baseline standard deviation is ${\hat{\tau }}_0=15.785582$ kg, and the between-person slope standard deviation is ${\hat{\tau }}_1=2.738666$ kg/week. Their estimated correlation $\hat{\rho }=0.117$ is weakly positive, giving random-effect covariance about $5.058$ kg${}^2$/week; its uncertainty is not supplied. The measurement-error standard deviation is $\hat{\sigma }=9.923280$ kg. The printed $-0.038$ instead describes the correlation between the estimated fixed effects, not between the subject random effects. These statistical parameter estimates come from restricted maximum likelihood; the model comparison uses the separate maximum likelihood estimation fits.

The population mean fitted trajectory is $61.09286+2.83143t$ kg. HenceUsing the reported slope standard error, an approximate 95% confidence interval for the population mean gain is $28.3143\pm 1.96(2.984464)=(22.46,34.16)$ kg; a Student t confidence interval with 499 statistical degrees of freedom is almost identical.

Successful individuals can improve far more than the average. Their latent ten-week gains have fitted normal distributionA clear estimate for an upper-performing group uses a between-person slope quantile: the 95th percentile is $28.3143+1.645(27.38666)\simeq 73.4$ kg, and the 97.5th percentile is about $82.0$ kg. The upper 5% of fitted underlying gains begin around 73 kg. These are person-to-person performance quantiles, not confidence intervals for the population mean. Identifying the best observed trainee would require that person's data or fitted subject random effects; the aggregate output cannot identify a literal maximum. If performance means the observed difference of endpoint readings, add the measurement-error variance $2{\sigma }^2$ to the latent gain variance.

The preferred cumulative-response logistic model estimatesIts logit link describes conditional smoking-free probability given baseline predictors and prior successful weeks. Holding the other predictors fixed, males have $e^{-0.364092}=0.695$ times the female success odds; the reported p-value is $0.0152$, and the approximate 95% odds ratio confidence interval is $(0.518,0.932)$. Age has estimated odds ratio $e^{0.001224}=1.0012$ per additional year, with p-value $0.918$, giving little evidence for an age association in this fit.

The combined treatment has conditional success odds ratio $e^{0.327118}=1.387$ versus the reference treatment, with approximate 95% confidence interval $(1.035,1.859)$ and p-value $0.0285$. The fitted conditional odds are about 39% higher for the combined treatment. The trial randomization supports treatment comparisons, but conditioning on accumulated post-treatment outcomes means this coefficient is not directly the marginal total treatment effect.

Each previous successful week multiplies current success odds by $e^{0.399296}=1.491$, with approximate 95% confidence interval $(1.329,1.673)$ and very small p-value $1.06\times 10^{-11}$. This is strong fitted persistence. It can reflect true state dependence, unobserved heterogeneity, or an omitted calendar-time trend; this fit alone cannot distinguish them. The baseline intercept implies success probability ${\mathrm{logit}}^{-1}(-1.417630)\simeq 0.195$ for a reference-treatment female aged zero with no previous success. That age is outside the study's useful interpretation range, so the intercept chiefly anchors the regression. The Bernoulli distribution dispersion parameter is fixed at one, and the residual binomial deviance is 1122 on 995 statistical degrees of freedom. With individual binary outcomes, comparing that binomial deviance mechanically to a chi-squared distribution is not a reliable general goodness-of-fit test.